A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
Cheap, light-weight and portable, the advanced nebuliser delivers precise drug doses to patients with life-threatening or debilitating lung conditions including cancer, tuberculosis, asthma and cystic fibrosis.
But the Respite(TM) nebuliser also has the potential to be used to administer insulin to people with diabetes or to painlessly vaccinate infants currently subjected to needles.
The patented technology is among 10 RMIT-developed technologies to be showcased in Singapore next week at TechInnovation 2015, a premier industry-to-technology event (September 22-23).
